Secondly, as will be explored further below, IgA mAbs are known to be highly effective at recruiting immune cells, and neutrophils in particular, to deliver potent killing mechanisms, making the IgA–FcαRI axis an important target in control of various cancers and infections. This evidence concerns the gene CD79A and cancer.